Clinical Trial Update: Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pharmacodynamic activity of P-321 ophthalmic solution vs placebo in dry eye disease; study terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• P 321 Ophthalmic Solution

Snippet

Sponsor: Parion Sciences | Conditions: Dry Eye Disease | Phase 2 | Status: TERMINATED | Results posted: 2018-01-19